C’mon, Joe. I don’t need to sign an NDA if you put out a PR with sales projections for your business unit. If the number is significant in any way, such info would provide more of a boost for the SP than any dividend you could issue or any future acquisition you could announce right now. Investors want to see revenues, my friend.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links